Advances and future directions in the targeting of HER2-positive breast cancer: Implications for the future

Por Subbiah, Ishwaria M., Gonzalez-Angulo, Ana Maria
Publicado em 2014

Cardiovascular Toxicity Profiles of Vascular-Disrupting Agents

Por Subbiah, Ishwaria M., Lenihan, Daniel J., Tsimberidou, Apostolia M.
Publicado em 2011

Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape

Por Subbiah, Ishwaria M., Tsimberidou, Apostolia, Subbiah, Vivek, Janku, Filip, Roy-Chowdhuri, Sinchita, Hong, David S.
Publicado no Oncoscience (2017)

Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma

Por Subbiah, Ishwaria M., Blackmon, Shanda H., Correa, Arlene M., Kee, Bryan, Vaporciyan, Ara A., Swisher, Stephen G., Eng, Cathy
Publicado em 2014

Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical...

Por Subbiah, Ishwaria M., Tang, Chad, Rao, Arvind, Falchook, Gerald S., Subbiah, Vivek, Tsimberidou, Apostolia M., Karp, Daniel, Kurzrock, Razelle, Hong, David S.
Publicado no Oncotarget (2018)

Treatment outcome and prognostic indicators in 94 cases of fibrolamellar hepatocellular carcinoma

Por Kaseb, Ahmed O, Shama, Mohamed, Sahin, Ibrahim Halil, Nooka, Ajay, Hassabo, Hesham M, Vauthey, Jean-Nicolas, Aloia, Thomas, Abbruzzese, James L, Subbiah, Ishwaria M, Janku, Filip, Curley, Steven, Hassan, Manal M
Publicado em 2013

Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials

Por Subbiah, Ishwaria M., Falchook, Gerald S., Kaseb, Ahmed O., Hess, Kenneth R., Tsimberidou, Apostolia M., Fu, Siqing, Subbiah, Vivek, Hong, David S., Naing, Aung, Sarina, A. Piha-Paul, Akmal, Owais, Janku, Filip, Kurzrock, Razelle
Publicado no Oncotarget (2015)

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases

Por Subbiah, Ishwaria M., Lei, Xiudong, Weinberg, Jeffrey S., Sulman, Erik P., Chavez-MacGregor, Mariana, Tripathy, Debu, Gupta, Rohan, Varma, Ankur, Chouhan, Jay, Guevarra, Richard P., Valero, Vicente, Gilbert, Mark R., Gonzalez-Angulo, Ana M.
Publicado no J Clin Oncol (2015)

Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials

Por Sen, Shiraj, Hess, Kenneth, Hong, David S, Naing, Aung, Piha-Paul, Sarina, Janku, Filip, Fu, Siqing, Subbiah, Ishwaria M, Liu, Holly, Khanji, Rahil, Huang, Le, Moorthy, Shhyam, Karp, Daniel D, Tsimberidou, Apostolia, Meric-Bernstam, Funda, Subbiah, Vivek
Publicado no Br J Cancer (2018)

Targeted Therapy of Advanced Gallbladder Cancer and Cholangiocarcinoma with Aggressive Biology: Eliciting Early Response Signals from Phase 1 trials

Por Subbiah, Ishwaria M., Subbiah, Vivek, Tsimberidou, Apostolia M., Naing, Aung, Kaseb, Ahmed O., Javle, Milind, Fu, Siqing, Hong, David S., Piha-Paul, Sarina, Wheler, Jennifer J., Hess, Kenneth R., Janku, Filip, Falchook, Gerald S., Wolff, Robert A, Kurzrock, Razelle
Publicado em 2013

STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harbo...

Por Subbiah, Vivek, McMahon, Caitlin, Patel, Shreyaskumar, Zinner, Ralph, Silva, Elvio G, Elvin, Julia A., Subbiah, Ishwaria M., Ohaji, Chimela, Ganeshan, Dhakshina Moorthy, Anand, Deepa, Levenback, Charles F., Berry, Jenny, Brennan, Tim, Chmielecki, Juliann, Chalmers, Zachary R., Mayfield, John, Miller, Vincent A., Stephens, Philip J., Ross, Jeffrey S., Ali, Siraj M.
Publicado no J Hematol Oncol (2015)